相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Unlocking the potential of agonist antibodies for treating cancer using antibody engineering
Harkamal S. Jhajj et al.
TRENDS IN MOLECULAR MEDICINE (2023)
Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
Lukas Kraehenbuehl et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
TRAF6 autophagic degradation by avibirnavirus VP3 inhibits antiviral innate immunity via blocking NFKB/NF-κB activation
Tingjuan Deng et al.
AUTOPHAGY (2022)
TRAF6 signaling pathway in T cells regulates anti-tumor immunity through the activation of tumor specific Th9 cells and CTLs
Astri Dewayani et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)
Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation
Alan Kennedy et al.
NATURE IMMUNOLOGY (2022)
Regulation of CTLA-4 recycling by LRBA and Rab11
Daniel Janman et al.
IMMUNOLOGY (2021)
Immune checkpoint inhibitors in melanoma
Matteo S Carlino et al.
LANCET (2021)
Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer
Ying Ma et al.
GASTROENTEROLOGY (2020)
Anti-VEGF Treatment Enhances CD8+ T-cell Antitumor Activity by Amplifying Hypoxia
Patricia E. de Almeida et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Real-world efficacy and safety data of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanoma
Akira Takahashi et al.
JOURNAL OF DERMATOLOGY (2020)
The Conserved Non-coding Sequences CNS6 and CNS9 Control Cytokine-Induced Rorc Transcription during T Helper 17 Cell Differentiation
Dehui Chang et al.
IMMUNITY (2020)
Autophagy-lysosome inhibitor chloroquine prevents CTLA-4 degradation of T cells and attenuates acute rejection in murine skin and heart transplantation
Jikai Cui et al.
THERANOSTICS (2020)
TRAF6 directs FOXP3 localization and facilitates regulatory T-cell function through K63-linked ubiquitination
Xuhao Ni et al.
EMBO JOURNAL (2019)
OX40 stimulation and PD-L1 blockade synergistically augment HBV-specific CD4 T cells in patients with HBeAg-negative infection
Felix Johannes Jacobi et al.
JOURNAL OF HEPATOLOGY (2019)
Hijacking antibody-induced CTLA-4 lysosomal degradation for safer and more effective cancer immunotherapy
Yan Zhang et al.
CELL RESEARCH (2019)
Immune-Checkpoint Protein VISTA Regulates Antitumor Immunity by Controlling Myeloid Cell-Mediated Inflammation and Immunosuppression
Wenwen Xu et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Requirement for p62 acetylation in the aggregation of ubiquitylated proteins under nutrient stress
Zhiyuan You et al.
NATURE COMMUNICATIONS (2019)
OX40 expression in neutrophils promotes hepatic ischemia/reperfusion injury
Hua Jin et al.
JCI INSIGHT (2019)
Agonist OX40 immunotherapy improves survival in glioma-bearing mice and is complementary with vaccination with irradiated GM-CSF-expressing tumor cells
Nusrat Jahan et al.
NEURO-ONCOLOGY (2018)
Inhibition of TRAF6 ubiquitin-ligase activity by PRDX1 leads to inhibition of NFKB activation and autophagy activation
Yoon Min et al.
AUTOPHAGY (2018)
Th9 Cells Represent a Unique Subset of CD4+ T Cells Endowed with the Ability to Eradicate Advanced Tumors
Yong Lu et al.
CANCER CELL (2018)
Guidance of super-enhancers in regulation of IL-9 induction and airway inflammation
Xiang Xiao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Visualizing Dynamics of Cell Signaling In Vivo with a Phase Separation-Based Kinase Reporter
Qiang Zhang et al.
MOLECULAR CELL (2018)
Suppression of Tcf1 by Inflammatory Cytokines Facilitates Effector CD8 T Cell Differentiation
Maxime Danilo et al.
CELL REPORTS (2018)
The Immune Checkpoint Modulator OX40 and Its Ligand OX40L in NK-Cell Immunosurveillance and Acute Myeloid Leukemia
Tina Nuebling et al.
CANCER IMMUNOLOGY RESEARCH (2018)
FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells
Xiangbo Meng et al.
NATURE (2018)
Macrophage subpopulations and their impact on chronic allograft rejection versus graft acceptance in a mouse heart transplant model
Yue Zhao et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Ablation of Transcription Factor IRF4 Promotes Transplant Acceptance by Driving Allogenic CD4+ T Cell Dysfunction
Jie Wu et al.
IMMUNITY (2017)
Roles of the TRAF6 and Pellino E3 ligases in MyD88 and RANKL signaling
Sam Strickson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Quality of TCR signaling determined by differential affinities of enhancers for the composite BATF-IRF4 transcription factor complex
Arifumi Iwata et al.
NATURE IMMUNOLOGY (2017)
A three-signal model of T-cell lymphoma pathogenesis
Ryan A. Wilcox
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Safety and antitumour activity of durvalumab plus tremelimumab in non-small-cell lung cancer: a multicentre, phase 1b study
Scott Antonia et al.
LANCET ONCOLOGY (2016)
The K48-K63 Branched Ubiquitin Chain Regulates NF-κB Signaling
Fumiaki Ohtake et al.
MOLECULAR CELL (2016)
Belatacept and Long-Term Outcomes in Kidney Transplantation
Flavio Vincenti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood
Katrin Klocke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh et al.
SCIENCE (2016)
PD-1 Co-inhibitory and OX40 Co-stimulatory Crosstalk Regulates Helper T Cell Differentiation and Anti-Plasmodium Humoral Immunity
Ryan A. Zander et al.
CELL HOST & MICROBE (2015)
Tumor necrosis factor receptor- associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system
Matthew C. Walsh et al.
IMMUNOLOGICAL REVIEWS (2015)
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
Dirk Schadendorf et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy
Bernice Lo et al.
SCIENCE (2015)
MiR-146a regulates the TRAF6/TNF-axis in donor T cells during GVHD
Natalie Stickel et al.
BLOOD (2014)
Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations
Desiree Schubert et al.
NATURE MEDICINE (2014)
HTLV-1 Tax Stabilizes MCL-1 via TRAF6-Dependent K63-Linked Polyubiquitination to Promote Cell Survival and Transformation
Young Bong Choi et al.
PLOS PATHOGENS (2014)
Exposure-Response Relationships of the Efficacy and Safety of Ipilimumab in Patients with Advanced Melanoma
Yan Feng et al.
CLINICAL CANCER RESEARCH (2013)
OX40 signaling favors the induction of TH9 cells and airway inflammation
Xiang Xiao et al.
NATURE IMMUNOLOGY (2012)
TLR signalling augments macrophage bactericidal activity through mitochondrial ROS
A. Phillip West et al.
NATURE (2011)
The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses
Lucy S. K. Walker et al.
NATURE REVIEWS IMMUNOLOGY (2011)
TRAF6 inhibits Th17 differentiation and TGF-β-mediated suppression of IL-2
Pedro J. Cejas et al.
BLOOD (2010)
Foxo Transcription Factors Control Regulatory T Cell Development and Function
Yann M. Kerdiles et al.
IMMUNITY (2010)
CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance
Josef Kurtz et al.
BLOOD (2009)
Enhancing CD8 T-cell memory by modulating fatty acid metabolism
Erika L. Pearce et al.
NATURE (2009)
Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4) - A novel strategy for the treatment of melanoma and other malignancies
Steven J. O'Day et al.
CANCER (2007)
Induction of the CTLA-4 gene in human lymphocytes is dependent on NFAT binding the proximal promoter
Heather M. Gibson et al.
JOURNAL OF IMMUNOLOGY (2007)
Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation
Chunxia Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis
Carolyn G. King et al.
NATURE MEDICINE (2006)
Caspase-8 regulation by direct interaction with TRAF6 in T cell receptor-induced NF-κB activation
Nicolas Bidere et al.
CURRENT BIOLOGY (2006)
Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4
Kimberly E. Beck et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
CD4+CD25+ immunoregulatory T cells:: New therapeutics for graft-versus-host disease
JL Cohen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
分享论文
